Novo Nordisk: How Low Is Too Low? (Downgrade, Technical Analysis)

MacroGirl2.16K FollowersFollow5ShareSavePlay(7min)CommentsSummaryNovo Nordisk A/S has seen its stock fall sharply, driven by a dramatic slowdown in EPS growth and weak 2026 guidance.A large drop was justified. This article looks at whether it could be overdone.Technical analysis suggests potential support at $36.80 and $29, which would be back to 2018-2020 levels. The company has grown significantly since then. Victor Golmer/iStock Editorial via Getty Images Bad news tends to come in bunches, and that's certainly been the case for Novo Nordisk A/S (NVO). As investors, we can try to anticipate the news flow, but without a crystal ball, the bestThis article was written byMacroGirl2.16K FollowersFollowMy approach is long-term and I focus on investing in macro ideas through low risk ETFs and CEFs. I have traded stocks and currencies for nearly ten years and currently run a family fund with my partner and fellow SA contributor Andrew McElroy. I also invest in real estate and am a freelance writer and contributor to Matrixtrade.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in NVO over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.